Celularity Inc
CELU
NASDAQ
Biotechnology
$0.70
USD
0.00 (+0.07%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $20.26M
Volume 11.4K
Revenue
$26.55M
TTM
-51.0%
YoY
Gross Margin
24%
TTM
-66.3%
YoY
Net Income
$-91.72M
TTM
-58.4%
YoY
Operating Cash Flow
$-13.25M
TTM
-107.1%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
Revenue | 18.1 | 11.4 | 5.7 | 5.3 | 4.1 |
YoY Growth | +49.7% | -22.2% | -52.6% | -43.2% | -77.4% |
Cost of Revenue | 7.3 | 3.6 | 5.2 | 3.9 | 7.4 |
Gross Profit | 10.8 | 7.9 | 0.5 | 1.4 | -3.3 |
Selling, General & Administrative | 16.1 | 14.3 | 12.6 | 9.3 | 15.1 |
Other Operating Expenses | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 20.1 | 18.4 | 16.4 | 14.3 | 18.8 |
Operating Income | -9.3 | -10.5 | -15.9 | -12.9 | -22.1 |
EBITDA | -7.6 | -8.7 | -14.0 | -11.1 | -20.2 |
Other Income / Expense | -8.0 | -6.9 | -6.8 | -8.8 | -1.5 |
Total Other Income / Expense | -4.0 | -9.3 | -8.7 | -10.2 | -2.3 |
Income Before Income Taxes | -13.3 | -19.8 | -24.5 | -23.1 | -24.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -13.3 | -19.8 | -24.5 | -23.1 | -24.4 |
Consolidated Net Income / Loss | -13.3 | -19.8 | -24.5 | -23.1 | -24.4 |
Net Income Attributable to Common Shareholders | -13.3 | -19.8 | -24.5 | -23.1 | -24.4 |
Basic EPS | -$0.59 | -$0.84 | -$1.02 | -$0.88 | -$0.86 |
Diluted EPS | -$0.59 | -$0.84 | -$1.02 | -$0.88 | -$0.86 |
Basic Shares Outstanding | 21.9M | 23.5M | 24.0M | 26.3M | 28.5M |
Diluted Shares Outstanding | 21.9M | 23.5M | 24.0M | 26.3M | 28.5M |